We are live on ! Find out more
MCM

Marathon Capital Management Portfolio holdings

AUM $445M
1-Year Est. Return 26.09%
This Fund
S&P 500
This Quarter Est. Return
+14.72%
1 Year Est. Return
+26.09%
3 Year Est. Return
+49.93%
5 Year Est. Return
+48.4%
10 Year Est. Return
+349.58%
AUM
$237M
AUM Growth
+$25.3M
Cap. Flow
-$2.53M
Cap. Flow %
-1.07%
Top 10 Hldgs %
70.48%
Holding
93
New
6
Increased
30
Reduced
26
Closed
8

Top Buys

Rank Stock Value
1
OZK icon
Bank OZK
OZK
+$1.68M
2
ENZ
Enzo Biochem, Inc.
ENZ
+$1.52M
3
DD icon
DuPont de Nemours
DD
+$1.4M
4
KN icon
Knowles
KN
+$929K
5
GLUU
Glu Mobile Inc.
GLUU
+$923K

Sector Composition

Rank Sector Weight
1 Financials 53.6%
2 Technology 16.18%
3 Industrials 5.78%
4 Healthcare 5.53%
5 Consumer Discretionary 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
1
T. Rowe Price
TROW
$25.1B
$124M 52.35%
1,371,450
-29,775
-2% -$2.46M
PLPM
2
DELISTED
Planet Payment, Inc
PLPM
$6.84M 2.88%
1,593,700
-44,800
-3% -$166K
HDSN
3
Hudson Technologies
HDSN
$260M
$6.08M 2.56%
777,975
-151,950
-16% -$1.32M
OIG
4
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$5.96M 2.51%
40,406
+136
+0.3% +$19.5K
SSNI
5
DELISTED
Silver Spring Networks, Inc.
SSNI
$5.33M 2.24%
329,435
-49,825
-13% -$626K
TSEM icon
6
Tower Semiconductor
TSEM
$26.5B
$4.29M 1.81%
139,565
-17,985
-11% -$490K
CRCM
7
DELISTED
CARE.COM, INC.
CRCM
$4.12M 1.74%
259,485
-1,965
-0.8% -$29.1K
DSKE
8
DELISTED
Daseke, Inc. Common Stock
DSKE
$3.65M 1.54%
279,900
+39,800
+17% +$496K
DD icon
9
DuPont de Nemours
DD
$18.3B
$3.55M 1.49%
20,250
+8,388
+71% +$1.4M
JNJ icon
10
Johnson & Johnson
JNJ
$609B
$3.23M 1.36%
24,857
-443
-2% -$58.7K
ABB
11
DELISTED
ABB Ltd
ABB
$3.01M 1.27%
121,512
-5,837
-5% -$140K
GLW icon
12
Corning
GLW
$133B
$2.82M 1.19%
94,353
-2,218
-2% -$65.7K
GSK icon
13
GSK
GSK
$104B
$2.82M 1.19%
55,508
+20
+0% +$1.01K
CY
14
DELISTED
Cypress Semiconductor
CY
$2.81M 1.18%
186,850
-100
-0.1% -$1.4K
GE icon
15
GE Aerospace
GE
$364B
$2.72M 1.14%
23,438
-263
-1% -$31.8K
ENZ
16
DELISTED
Enzo Biochem, Inc.
ENZ
$2.64M 1.11%
252,225
+137,225
+119% +$1.52M
DMRC icon
17
Digimarc Corp
DMRC
$134M
$2.63M 1.11%
71,900
+12,295
+21% +$384K
CELG
18
DELISTED
Celgene Corp
CELG
$2.49M 1.05%
17,100
-350
-2% -$47.7K
MSFT icon
19
Microsoft
MSFT
$2.93T
$2.48M 1.04%
33,303
+1,361
+4% +$99.4K
CEF icon
20
Sprott Physical Gold and Silver Trust
CEF
$7.3B
$2.42M 1.02%
191,250
+12,950
+7% +$164K
CALY
21
Callaway Golf Company
CALY
$3.48B
$2.28M 0.96%
158,247
+466
+0.3% +$6.17K
VOD icon
22
Vodafone
VOD
$36.2B
$2.19M 0.92%
77,091
-800
-1% -$23.2K
INWK
23
DELISTED
InnerWorkings, Inc.
INWK
$2.13M 0.9%
189,125
-750
-0.4% -$8.31K
ORBC
24
DELISTED
ORBCOMM, Inc.
ORBC
$2.13M 0.9%
203,025
+30,500
+18% +$337K
LAND
25
Gladstone Land Corp
LAND
$378M
$2.06M 0.87%
151,390
-29,800
-16% -$379K

Similar funds

Marathon Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Marathon Capital Management held 93 positions worth $237M, up 12% from $212M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Marathon Capital Management's Q3 2017 filing shows 6 new, 30 increased, 26 reduced and 8 closed positions. Its largest new stake was Bank OZK: 37,700 shares worth $1.81M. The largest sale was T. Rowe Price, an estimated $2.46M.

By sector, the portfolio is most concentrated in Financials at 54% of assets, up from 50% a quarter earlier, followed by Technology and Industrials.

  • Marathon Capital Management's largest Q3 2017 buy was Bank OZK: 37,700 shares worth $1.81M.
  • Marathon Capital Management added most to Enzo Biochem, Inc. in Q3 2017, an estimated $1.52M increase.
  • Marathon Capital Management's biggest Q3 2017 reduction was T. Rowe Price, cutting an estimated $2.46M.
  • Marathon Capital Management fully exited Howmet Aerospace in Q3 2017, selling an estimated $1.87M.
  • Marathon Capital Management's ten largest holdings make up 70% of its $237M portfolio in Q3 2017.
  • Marathon Capital Management opened 6 new positions and closed 8 in Q3 2017.
  • Marathon Capital Management's portfolio value rose 12% quarter-over-quarter to $237M.

Based on Marathon Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.